Blackrock Neurotech’s MoveAgain Brain-Computer Interface System Receives Breakthrough Device Designation from the FDA

SALT LAKE CITY, Nov. 16, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface technology, today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its groundbreaking MoveAgain Brain Computer Interface (BCI) System. The first-of-its-kind system is expected to provide immobile patients the ability to control a mouse cursor, keyboard, mobile…

Read more

Hearing Restoration For The Deaf: Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

SALT LAKE CITY, Sept. 15, 2021 /PRNewswire/ — Blackrock Neurotech, a leading provider of brain computer interface (BCI) technology for human patients, has announced plans to invest in a novel auditory nerve implant (ANI) device that restores hearing for the deaf. The ANI device technology is being developed as part of an NIH-supported effort between the University of Minnesota,…

Read more

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution

SOLANA BEACH, Calif. and SALT LAKE CITY, July 21, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a joint agreement with Blackrock Neurotech to develop an automated surgical solution for implanting Brain Computer Interfaces (BCIs) into patients with…

Read more